{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:47:41Z","timestamp":1792320461752,"version":"4.4.0"},"reference-count":6,"publisher":"Jaypee Brothers Medical Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.59556\/japi.72.0735","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:23:46Z","timestamp":1750659826000},"page":"e45-e46","source":"Crossref","is-referenced-by-count":2,"title":["A Case Involving Linezolid-induced Fatal Lactic Acidosis and Pancytopenia"],"prefix":"10.59556","volume":"72","author":[{"given":"Kundan","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islahuzzama Salahuddin","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Barthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20250623062342_B1","first-page":"606\u2013","article-title":"Linezolid for the treatment of patients with mycobacterial infections: a systematic review.","volume":"11:","author":"Ntziora","year":"2007;","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20250623062342_B2","doi-asserted-by":"crossref","first-page":"387\u2013","DOI":"10.1183\/09031936.00009509","article-title":"A retrospective TBNET assesment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.","volume":"34:","author":"Milgori","year":"2009;","journal-title":"Eur Respir J"},{"key":"key20250623062342_B3","doi-asserted-by":"crossref","first-page":"47\u2013","DOI":"10.1016\/j.ijid.2014.12.009","article-title":"Incidence and risk factors of linezolid-induced lactic acidosis.","volume":"31:","author":"Im","year":"2015;","journal-title":"Int J Infect Dis"},{"issue":"(6):","key":"key20250623062342_B4","doi-asserted-by":"crossref","first-page":"1422\u2013","DOI":"10.1111\/jcpt.13245","article-title":"Linezolid and the risk of lactic acidosis: data mining and analysis of the FDA adverse event reporting system.","volume":"45","author":"Dai","year":"2020;","journal-title":"J Clin Pharm Ther"},{"issue":"(12):","key":"key20250623062342_B5","doi-asserted-by":"crossref","first-page":"1784\u2013","DOI":"10.1592\/phco.26.12.1784","article-title":"Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists.","volume":"26","author":"Huang","year":"2006;","journal-title":"Pharmacotherapy"},{"issue":"(2):","key":"key20250623062342_B6","doi-asserted-by":"crossref","first-page":"108\u2013","DOI":"10.1016\/j.jsps.2021.12.021","article-title":"Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: a case report.","volume":"30","author":"Zhang","year":"2022;","journal-title":"Saudi Pharm J"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:23:47Z","timestamp":1750659827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-11-e45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.59556\/japi.72.0735"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0735","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}